About 8 results found for searched term "ML-18" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1828 | Tandutinib | FLT3 |
| MLN518, CT53518 | ||
| Tandutinib (MLN518), previously known as CT53518, is an orally active multitargeted tyrosine kinase inhibitor of FLT3, PDGFR and c-Kit. | ||
| M6971 | ML 218 hydrochloride | Others |
| ML 218 hydrochloride is a ca 2+ channel blocker (T-type). | ||
| M8912 | ML-18 | Bombesin Receptor |
| ML18 is Bombesin receptor subtype 3 (BRS-3) antagonist (IC50 = 4.8 μM). | ||
| M13650 | ML-60218 | DNA/RNA Synthesis |
| ML-60218 is a broad-spectrum RNA pol III inhibitor, with IC50s of 32 and 27 μM for Saccharomyces cerevisiae and human. | ||
| M13758 | MLCK inhibitor peptide 18 | Myosin |
| MLCK inhibitor peptide 18 is a myosin light chain kinase (MLCK) inhibitor with an IC50 of 50 nM, and inhibits CaM kinase II only at 4000-fold higher concentrations. | ||
| M14901 | Tandutinib hydrochloride | FLT3 |
| MLN518 hydrochloride; CT53518 hydrochloride | ||
| Tandutinib hydrochloride (MLN518 hydrochloride) is a potent and selective inhibitor of the FLT3 with an IC50 of 0.22 μM, and also inhibits c-Kit and PDGFR with IC50s of 0.17 μM and 0.20 μM, respectively. | ||
| M29031 | ML418 | Potassium Channel |
| ML418 is a potent, selective and CNS penetrating Kir7.1 potassium channel blocker. ML418 inhibits Kir7.1 with an IC50 value of 0.31 μM. ML418 can be used for the research of neurological, cardiovascular, endocrine and muscle disorders. | ||
| M45102 | ML188 | Anti-infection |
| ML188 is a first-in-class probe and also a selective non-covalent SARS-CoV 3CLpro inhibitor with an IC50 of 1.5 μM. antiviral activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
